Matthew J.Silveira (Matt)

Partner

San Francisco + 1.415.875.5715

Matt Silveira focuses his practice on complex civil litigation in federal and state courts, where he primarily handles legal strategy, dispositive motions, and appeals. He has experience across a wide range of industries and subject matters, including financial markets, antitrust, intellectual property, technology, life sciences, health care, and labor and employment.

Matt has led teams in courts around the country, including in California, New York, and the Ninth and Federal Circuits. He has successfully briefed and argued motions after trial, at the pleading stage, on summary judgment, in arbitration proceedings, and in connection with requests for injunctive relief, in addition to extensive experience with appeals and writ petitions. Representative engagements include: obtaining dismissal of a California False Claims Act complaint against several financial institutions serving as remarketing agents of variable-rate municipal bonds; securing the dismissal of a series of market manipulation and consumer fraud lawsuits filed against a cryptocurrency derivatives trading platform in California state and federal courts; obtaining and successfully defending on appeal a summary judgment of noninfringement for a semiconductor component manufacturer; securing and enforcing an arbitration award forcing a union to withdraw a statewide ballot initiative limiting hospital executive compensation; and representing several hospitals in challenges to union-backed local initiatives seeking to cap the compensation that health care providers may receive from insurers.

Matt also maintains a varied pro bono practice, including the representation of civil rights plaintiffs in the federal courts and immigration clients in proceedings before the Ninth Circuit and the Board of Immigration Appeals.

Erfahrung

  • NXP defends multi-jurisdiction patent infringement suits involving RFID technologyJones Day represents NXP U.S.A. Inc. against a competitor in a global patent dispute involving more than 50 patents.
  • Merck wins bench trial over patent term extension issue in Hatch-Waxman multi-party dispute involving BRIDION®Jones Day is representing Merck Sharp & Dohme, B.V. in Hatch-Waxman patent infringement actions originally against 16 generic drug maker defendant groups, relating to the defendant groups' submissions of Abbreviated New Drug Applications (ANDA) to the FDA seeking approval of generic versions of BRIDION®, a first-in-class agent for the reversal of certain types of neuromuscular blockade induced in adults undergoing surgery.
  • Global financial institution defends claims in VRDO mattersJones Day is defending a global financial institution in several matters related to its activities as remarketing agent for variable rate demand obligations (“VRDOs”) issued by agencies or units of state and local government.
  • Sutter Health wins complete defense verdict in landmark antitrust class actionJones Day won a complete defense jury verdict for Sutter Health in a landmark antitrust class action seeking $1.2 billion in treble damages.
  • HDR Global Trading obtains dismissal with prejudice in 33-count lawsuitJones Day client HDR Global Trading Limited ("HDR"), the Seychelles-incorporated owner and operator of the BitMEX cryptocurrency derivatives trading platform, obtained dismissal with prejudice of a 33-count lawsuit alleging violations of the Commodity Exchange Act, RICO, and various California statutory and common law claims.
  • Large regional property manager sells $1 billion portfolio of 27 multifamily propertiesJones Day represented a large regional property manager in its $1 billion sale of a portfolio of 27 multifamily properties consisting of over 500 buildings and close to 8,000 units.
  • PI Advanced Materials obtains CAFC affirmance of summary judgment win in patent case regarding polyimide filmsJones Day successfully obtained a Federal Circuit affirmance of a summary judgment win of non-infringement on behalf of PI Advanced Materials Co., Ltd. ("PIAM", formerly SKC Kolon PI, Inc. ("SKPI")).
  • Micron Technology asserts trade secret and RICO claims, establishes U.S. jurisdiction over foreign defendants under DTSAJones Day represents Micron Technology, Inc. as a plaintiff in a trade secret and RICO lawsuit against Taiwanese and Chinese entities accused of theft of Micron's semiconductor processing technology.
  • Xilinx defends against patent claims by Japanese sovereign patent fund IP BridgeJones Day represented Xilinx Inc., the industry leader in field programmable gate arrays, in its patent dispute with Godo Kaisha IP Bridge 1 ("IP Bridge"), a Japanese sovereign patent fund that holds approximately 800 patents and attempts to generate revenues by enforcing patents against U.S. operating companies.
  • Sherwin-Williams defends lead paint actions brought by California cities and countiesJones Day is defending The Sherwin-Williams Company against claims brought by ten of California's largest cities and counties.
  • Adocia prevails in biopharma license agreement dispute in international arbitrationJones Day won a binding arbitration award for French biopharmaceutical company, Adocia S.A., in a license agreement dispute against Eli Lilly and Company.
  • HP obtains writ of mandamus in patent litigationOn behalf of HP Inc., Jones Day obtained a rare writ of mandamus from the Federal Circuit ordering Judge Schroeder from the Eastern District of Texas to transfer a patent litigation involving Google Chrome products to the Northern District of California.
  • Synopsys reaches agreement with Mentor Graphics in competitor patent caseJones Day served as lead trial counsel for Synopsys Inc. in competitor patent litigation against Mentor Graphics Corporation following the Federal Circuit’s remand of the case to the district court.
  • Xilinx proves unpatentability of third party patent claims in USPTO IPR and at Federal CircuitJones Day successfully represented Xilinx, Inc. in defending patent claims asserted by PLL Technologies, Inc. in the District of Delaware as well as before the Patent Trial and Appeal Board (PTAB) in an inter partes review (IPR) challenge to the patent and on the subsequent appeal to the Federal Circuit.
  • Synopsys obtains reversal of PTAB unpatentability decisionJones Day obtained a rare reversal of the PTAB on behalf of Synopsys, Inc. in its ongoing battle with ATopTech, Inc.
  • Xilinx obtains Federal Circuit decisions affirming dismissal under Alice and setting personal jurisdiction precedentJones Day represents Xilinx, Inc. in multiple venues against patent infringement assertions relating to integrated circuit testing technology.
  • Synopsys wins $30 million jury verdict and obtains permanent injunction in software IP actionAfter a two-week trial, Jones Day obtained a $30.4 million jury verdict on behalf of Synopsys, Inc. on its copyright infringement claim against ATopTech, Inc. Synopsys is a leader in electronic design automation (EDA) software.
  • Millennium Laboratories wins Ninth Circuit reversal in trade dress and unfair competition litigationJones Day won a reversal of summary judgment for Millennium Laboratories, Inc. in a Ninth Circuit appeal of a trade dress and unfair competition dispute.
  • Lennar resolves putative product liability and consumer fraud class action lawsuitsJones Day client Lennar Corporation obtained the voluntary dismissal of putative class action lawsuits against Lennar homebuilding subsidiaries in California and the settlement of nationwide putative class action lawsuits in Nevada and Minnesota after defeating bids for class certification, and defeating plaintiffs' attempt to appeal to the Ninth Circuit in the Nevada case.
  • Energy company eliminates $2 million in damages and attorney’s fees on appealOn October 21, 2015, Jones Day obtained a ruling by the California Court of Appeal reversing a jury award of $1.3 million dollars in punitive damages, $629,560.88 in attorney’s fees, and $10,000 under the Labor Code Private Attorney General Act for a Fortune 100 energy company.